Learn what retatrutide is, how this next‑generation triple agonist (GLP‑1, GIP, and glucagon) works for weight loss, obesity, and metabolic health, and see key phase 2 clinical trial results on body‑weight reduction and cardiometabolic benefits.
Learn what ensifentrine is, how its dual PDE3/4 inhibition works, and why it’s an emerging inhaled treatment option for COPD. Review its bronchodilatory and anti-inflammatory effects, phase 2b and phase 3 clinical trial results, and impact on lung function, symptoms, and exacerbations.
Learn what deucravacitinib is, how this first-in-class selective TYK2 inhibitor works, and why it’s changing the treatment landscape for moderate-to-severe plaque psoriasis and other autoimmune diseases, with data from pivotal phase 3 clinical trials.